Cite
HARVARD Citation
Schweitzer, P. et al. (n.d.). 0617 Solriamfetol Treatment of Excessive Daytime Sleepiness in Parkinson's Disease: Results from a Phase 2 Proof-of-Concept Trial. Sleep. pp. A245-A246. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schweitzer, P. et al. (n.d.). 0617 Solriamfetol Treatment of Excessive Daytime Sleepiness in Parkinson's Disease: Results from a Phase 2 Proof-of-Concept Trial. Sleep. pp. A245-A246. [Online].